About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Digital Pathology Market Size, Demand, Global Trends, Forecast to 2031
Digital Pathology Market

Digital Pathology Market Size, Share & Trends Analysis Report By Product (Device, Software, Communication Systems, Storage Systems), By Type (Human Pathology, Veterinary Pathology), By Application (Drug Discovery, Disease Diagnosis, Teleconsultation, Training and Education), By End-User (Pharmaceutical and Biotechnology Companies, Hospitals and Reference Laboratories, Academic and Research Institutes) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRHI795DR
Last Updated : November 21, 2024
Author : Debashree Bora
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Digital Pathology Market Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Device
        1. By Value
      3. Software
        1. By Value
      4. Communication Systems
        1. By Value
      5. Storage Systems
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Human Pathology
        1. By Value
      3. Veterinary Pathology
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Drug Discovery
        1. By Value
      3. Disease Diagnosis
        1. By Value
      4. Teleconsultation
        1. By Value
      5. Training and Education
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharmaceutical and Biotechnology Companies
        1. By Value
      3. Hospitals and Reference Laboratories
        1. By Value
      4. Academic and Research Institutes
        1. By Value
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Device
        1. By Value
      3. Software
        1. By Value
      4. Communication Systems
        1. By Value
      5. Storage Systems
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Human Pathology
        1. By Value
      3. Veterinary Pathology
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Drug Discovery
        1. By Value
      3. Disease Diagnosis
        1. By Value
      4. Teleconsultation
        1. By Value
      5. Training and Education
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharmaceutical and Biotechnology Companies
        1. By Value
      3. Hospitals and Reference Laboratories
        1. By Value
      4. Academic and Research Institutes
        1. By Value
    6. U.S.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Device
          1. By Value
        3. Software
          1. By Value
        4. Communication Systems
          1. By Value
        5. Storage Systems
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Human Pathology
          1. By Value
        3. Veterinary Pathology
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Drug Discovery
          1. By Value
        3. Disease Diagnosis
          1. By Value
        4. Teleconsultation
          1. By Value
        5. Training and Education
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Pharmaceutical and Biotechnology Companies
          1. By Value
        3. Hospitals and Reference Laboratories
          1. By Value
        4. Academic and Research Institutes
          1. By Value
    7. Canada
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Device
        1. By Value
      3. Software
        1. By Value
      4. Communication Systems
        1. By Value
      5. Storage Systems
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Human Pathology
        1. By Value
      3. Veterinary Pathology
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Drug Discovery
        1. By Value
      3. Disease Diagnosis
        1. By Value
      4. Teleconsultation
        1. By Value
      5. Training and Education
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharmaceutical and Biotechnology Companies
        1. By Value
      3. Hospitals and Reference Laboratories
        1. By Value
      4. Academic and Research Institutes
        1. By Value
    6. U.K.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Device
          1. By Value
        3. Software
          1. By Value
        4. Communication Systems
          1. By Value
        5. Storage Systems
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Human Pathology
          1. By Value
        3. Veterinary Pathology
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Drug Discovery
          1. By Value
        3. Disease Diagnosis
          1. By Value
        4. Teleconsultation
          1. By Value
        5. Training and Education
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Pharmaceutical and Biotechnology Companies
          1. By Value
        3. Hospitals and Reference Laboratories
          1. By Value
        4. Academic and Research Institutes
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Device
        1. By Value
      3. Software
        1. By Value
      4. Communication Systems
        1. By Value
      5. Storage Systems
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Human Pathology
        1. By Value
      3. Veterinary Pathology
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Drug Discovery
        1. By Value
      3. Disease Diagnosis
        1. By Value
      4. Teleconsultation
        1. By Value
      5. Training and Education
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharmaceutical and Biotechnology Companies
        1. By Value
      3. Hospitals and Reference Laboratories
        1. By Value
      4. Academic and Research Institutes
        1. By Value
    6. China
      1. By Product
        1. Introduction
          1. Product By Value
        2. Device
          1. By Value
        3. Software
          1. By Value
        4. Communication Systems
          1. By Value
        5. Storage Systems
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Human Pathology
          1. By Value
        3. Veterinary Pathology
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Drug Discovery
          1. By Value
        3. Disease Diagnosis
          1. By Value
        4. Teleconsultation
          1. By Value
        5. Training and Education
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Pharmaceutical and Biotechnology Companies
          1. By Value
        3. Hospitals and Reference Laboratories
          1. By Value
        4. Academic and Research Institutes
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Device
        1. By Value
      3. Software
        1. By Value
      4. Communication Systems
        1. By Value
      5. Storage Systems
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Human Pathology
        1. By Value
      3. Veterinary Pathology
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Drug Discovery
        1. By Value
      3. Disease Diagnosis
        1. By Value
      4. Teleconsultation
        1. By Value
      5. Training and Education
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharmaceutical and Biotechnology Companies
        1. By Value
      3. Hospitals and Reference Laboratories
        1. By Value
      4. Academic and Research Institutes
        1. By Value
    6. UAE
      1. By Product
        1. Introduction
          1. Product By Value
        2. Device
          1. By Value
        3. Software
          1. By Value
        4. Communication Systems
          1. By Value
        5. Storage Systems
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Human Pathology
          1. By Value
        3. Veterinary Pathology
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Drug Discovery
          1. By Value
        3. Disease Diagnosis
          1. By Value
        4. Teleconsultation
          1. By Value
        5. Training and Education
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Pharmaceutical and Biotechnology Companies
          1. By Value
        3. Hospitals and Reference Laboratories
          1. By Value
        4. Academic and Research Institutes
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. Rest of MEA
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Device
        1. By Value
      3. Software
        1. By Value
      4. Communication Systems
        1. By Value
      5. Storage Systems
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Human Pathology
        1. By Value
      3. Veterinary Pathology
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Drug Discovery
        1. By Value
      3. Disease Diagnosis
        1. By Value
      4. Teleconsultation
        1. By Value
      5. Training and Education
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharmaceutical and Biotechnology Companies
        1. By Value
      3. Hospitals and Reference Laboratories
        1. By Value
      4. Academic and Research Institutes
        1. By Value
    6. Brazil
      1. By Product
        1. Introduction
          1. Product By Value
        2. Device
          1. By Value
        3. Software
          1. By Value
        4. Communication Systems
          1. By Value
        5. Storage Systems
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Human Pathology
          1. By Value
        3. Veterinary Pathology
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Drug Discovery
          1. By Value
        3. Disease Diagnosis
          1. By Value
        4. Teleconsultation
          1. By Value
        5. Training and Education
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Pharmaceutical and Biotechnology Companies
          1. By Value
        3. Hospitals and Reference Laboratories
          1. By Value
        4. Academic and Research Institutes
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
    1. Digital Pathology Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Leica Biosystems
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Koninklijke Philips N.V.
    3. Hoffmann-La Roche Ltd
    4. 3DHISTECH
    5. Apollo Enterprise Imaging
    6. XIFIN
    7. Huron Digital Pathology
    8. Visiopharm A/S
    9. Corista
    10. Indica Labs
    11. Objective Pathology Services
    12. Sectra AB
    13. OptraSCAN
    14. Glencoe Software
    15. Inspirata, Inc
    16. Mikroscan Technologies
    17. Proscia Inc.
    18. Kanteron Systems
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Digital Health Market Insights The global digital health market size was valued at USD 239.23 billion in 2023 and is projected to reach USD 1,015.84 billion in 2032, growing at a CAGR of 17.34% over the forecast period (2024
Buy Now
Global Report
The Global Digital Utility Market Size was valued at USD 161.41 billion in 2021 and is projected to reach USD 428.20 billion by 2030 at a CAGR of 11.45% from 2022 to 2030. The utility industry is presented with a transformative opportunity by the ra
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.